Rab 7L1 Activators
Rab7L1 activators encompass diverse chemical compounds that indirectly promote the functional activity of Rab7L1 through modulation of various signaling pathways and cellular processes. Forskolin, by raising cAMP levels, indirectly stimulates Rab7L1-associated endosomal trafficking by enhancing PKA activity which could phosphorylate components of the retromer complex involving Rab7L1. Rab7L1 activators encompass a diverse range of chemical compounds that indirectly enhance the functionality of Rab7L1 through modulation of various cellular signaling pathways and processes. Forskolin, by increasing intracellular cAMP levels, indirectly stimulates Rab7L1's role in endosomal trafficking by enhancing PKA activity, which can phosphorylate components of the retromer complex where Rab7L1 is implicated. AICAR and Metformin, via AMPK activation, may boost Rab7L1-mediated autophagy by influencing autophagic flux, while Sphingosine-1-phosphate could facilitate Rab7L1's function in vesicle trafficking through its roles in lipid signaling. ML141's inhibition of Cdc42 and NSC 23766's inhibition of Rac1 could indirectly enhance Rab7L1's actions in cytoskeletal organization, affecting vesicular movement and positioning. Zoledronic acid and Bafilomycin A1, by altering prenylation of small GTPases and endosomal pH respectively, can influence Rab7L1's localization and function in trafficking pathways.
The functional activity of Rab7L1 is further influenced by compounds that affect phospholipid metabolism and protease activity. U73122, by inhibiting phospholipase C, may enhance Rab7L1's membrane recruitment, while ALLN, a calpain inhibitor, could preserve functional proteins that collaborate with Rab7L1 in trafficking operations. GW5074 and PD98059, by modulating the MAPK/ERK pathway, could indirectly affect Rab7L1's interaction with signaling molecules involved in endosomal maturation. Collectively, these activators, through their targeted effects on cellular processes and signaling, facilitate the enhancement of Rab7L1-mediated functions, such as vesicular trafficking and autophagy, without the need for direct upregulation of its expression or activation.
SEE ALSO...
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Forskolin | 66575-29-9 | sc-3562 sc-3562A sc-3562B sc-3562C sc-3562D | 5 mg 50 mg 1 g 2 g 5 g | $78.00 $153.00 $740.00 $1413.00 $2091.00 | 73 | |
Forskolin activates adenylyl cyclase, increasing cAMP levels which can enhance PKA activity. PKA phosphorylation events can influence the retromer complex, of which Rab7L1 is a constituent, thereby potentially enhancing Rab7L1's role in endosomal trafficking. | ||||||
AICAR | 2627-69-2 | sc-200659 sc-200659A sc-200659B | 50 mg 250 mg 1 g | $65.00 $280.00 $400.00 | 48 | |
AICAR activates AMP-activated protein kinase (AMPK), which can influence autophagic pathways. By activating AMPK, AICAR could enhance Rab7L1-mediated autophagy processes, as Rab7L1 is known to interact with the autophagy machinery. | ||||||
D-erythro-Sphingosine-1-phosphate | 26993-30-6 | sc-201383 sc-201383D sc-201383A sc-201383B sc-201383C | 1 mg 2 mg 5 mg 10 mg 25 mg | $165.00 $322.00 $570.00 $907.00 $1727.00 | 7 | |
Sphingosine-1-phosphate acts as a signaling lipid that can regulate endocytosis and autophagy. It may indirectly enhance Rab7L1’s function in vesicle trafficking by influencing these cellular processes. | ||||||
ML 141 | 71203-35-5 | sc-362768 sc-362768A | 5 mg 25 mg | $137.00 $512.00 | 7 | |
ML141 is a Cdc42 inhibitor, which can alter actin dynamics. Since actin is involved in vesicular trafficking, inhibiting Cdc42 could potentially enhance Rab7L1’s role in this process through changes in actin polymerization. | ||||||
Zoledronic acid, anhydrous | 118072-93-8 | sc-364663 sc-364663A | 25 mg 100 mg | $92.00 $256.00 | 5 | |
Zoledronic acid affects the prenylation of small GTPases. By inhibiting farnesyl pyrophosphate synthase, it can increase levels of unprenylated Rab7L1, which could alter its subcellular localization and enhance its function in trafficking. | ||||||
NSC 23766 | 733767-34-5 | sc-204823 sc-204823A | 10 mg 50 mg | $151.00 $609.00 | 75 | |
NSC 23766 inhibits Rac1, which modulates cytoskeletal organization. By affecting Rac1 activity, it could indirectly enhance Rab7L1's role in intracellular trafficking and membrane dynamics. | ||||||
Metformin-d6, Hydrochloride | 1185166-01-1 | sc-218701 sc-218701A sc-218701B | 1 mg 5 mg 10 mg | $292.00 $822.00 $1540.00 | 1 | |
Metformin activates AMPK, which, like AICAR, can enhance autophagic processes. Through AMPK activation, Metformin could indirectly promote Rab7L1's role in autophagy. | ||||||
Bafilomycin A1 | 88899-55-2 | sc-201550 sc-201550A sc-201550B sc-201550C | 100 µg 1 mg 5 mg 10 mg | $98.00 $255.00 $765.00 $1457.00 | 280 | |
Bafilomycin A1 inhibits the vacuolar-type H+-ATPase (V-ATPase), which can affect endosomal acidification. By modulating endosomal pH, it can impact Rab7L1’s function in endosomal maturation and trafficking. | ||||||
GW 5074 | 220904-83-6 | sc-200639 sc-200639A | 5 mg 25 mg | $106.00 $417.00 | 10 | |
GW5074 is a Raf kinase inhibitor which could modulate the MAPK/ERK pathway, potentially impacting Rab7L1's interactions with the retromer complex and thus its role in trafficking. | ||||||
PD 98059 | 167869-21-8 | sc-3532 sc-3532A | 1 mg 5 mg | $40.00 $92.00 | 212 | |
PD98059 is an MEK inhibitor, which also modulates the MAPK/ERK pathway. This could indirectly influence Rab7L1’s function in endosomal trafficking and autophagy by altering signaling events that regulate these processes. | ||||||